article Open AccessTop 1% cited
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Annals of the Rheumatic Diseases · 2022 · Vol. 82(1) · pp. 19–34
Sofía Ramiro✉(Leiden University Medical Center)Elena Nikiphorou(King's College London)Alexandre Sepriano(Leiden University Medical Center)Augusta Ortolan(University of Padua)Casper Webers(Maastricht University Medical Centre)Xenofon Baraliakos(Rheumazentrum Ruhrgebiet)Robert Landewé(Zuyderland Medisch Centrum)Filip Van den Bosch(Ghent University Hospital)B. BotevaAnn Bremander(Lund University)Philippe Carron(Ghent University Hospital)Adrian Ciurea(University Hospital of Zurich)F. van Gaalen(Leiden University Medical Center)Pál Géher(Semmelweis University)Lianne S. Gensler(University of California, San Francisco)Josef Hermann(Medical University of Graz)Manouk de Hooge(Ghent University)Markéta Hušáková(Charles University)Uta Kiltz(Rheumazentrum Ruhrgebiet)Clementina López‐Medina(Instituto Maimónides de Investigación Biomédica de Córdoba)Pedro Machado(London North West Healthcare NHS Trust)Helena Marzo‐Ortega(University of Leeds)Anna Moltó(Délégation Paris 5)Victoria Navarro‐CompánMichael J. Nissen(University Hospital of Geneva)Fernando Pimentel‐Santos(Universidade Nova de Lisboa)Denis Poddubnyy(Charité - Universitätsmedizin Berlin)Fabian Proft(Charité - Universitätsmedizin Berlin)Martín Rudwaleit(Klinikum Bielefeld)Mark TelkmanSizheng Steven Zhao(University of Manchester)Nelly Ziadé(Saint Joseph University)Désirée van der Heijde(Leiden University Medical Center)
Spondyloarthritis Studies and TreatmentsPsoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and TherapiesMedicineAxial spondyloarthritisPhysical therapySacroiliitisAnkylosing spondylitisInternal medicine
MeSH terms
AnalgesicsAnti-Inflammatory Agents, Non-SteroidalHumansSpondylitis, AnkylosingAntirheumatic AgentsSpondylarthritis
Funding
- Assessment of SpondyloArthritis international Society
Citations
832
FWCI
131.93
field-weighted impact
References
160
Percentile
100%
vs. same field & year
Citations per year
Cited by
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Annals of the Rheumatic Diseases · 2023 · 803 citations
References
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
Annals of the Rheumatic Diseases · 2008 · 1,037 citations
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
Annals of the Rheumatic Diseases · 2009 · 1,621 citations
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Annals of the Rheumatic Diseases · 2011 · 979 citations
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Gut · 2012 · 1,472 citations
Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial
Gut · 2007 · 1,030 citations
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
Annals of the Rheumatic Diseases · 2009 · 3,561 citations
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
Annals of the Rheumatic Diseases · 2010 · 783 citations
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Annals of the Rheumatic Diseases · 2017 · 1,541 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.